The Board of Elixinol Wellness Limited has accepted the resignation of Mr. Oliver Horn from the role of Global Chief Executive Officer (Global CEO) and Executive Director, effective 8 April 2022. Mr. Horn will remain with the business as a Non-Executive Director after that date. In line with the focus on continuing the ongoing strategic transformation, the Company has appointed Mr. Ronald (Ron) Dufficy, the Company's current Global Chief Financial Officer (Global CFO), as Interim Global CEO of Elixinol Wellness, effective 8 April 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | -20.00% | -.--% | -66.67% |
05-13 | Elixinol Wellness Receives AU$2.3 Million from Pet Releaf Stake Sale | MT |
04-18 | Transcript : Elixinol Wellness Limited - Shareholder/Analyst Call |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.67% | 3.51M | |
+41.87% | 113B | |
-9.67% | 36.88B | |
+30.64% | 36.27B | |
+24.61% | 34.85B | |
+31.54% | 22.75B | |
+38.73% | 21.95B | |
+3.51% | 9.37B | |
+11.64% | 8.65B | |
+165.00% | 8.04B |
- Stock Market
- Equities
- EXL Stock
- News Elixinol Wellness Limited
- Elixinol Wellness Limited Announces CEO Changes, Effective 8 April 2022